ARTICLE | Clinical News
Dara BioSciences preclinical data
November 16, 2009 8:00 AM UTC
In mouse models of diabetes, DB959 significantly lowered blood glucose levels and improved glucose tolerance compared with baseline. The company expects to begin Phase I testing of the dual peroxisom...